No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18 years.
about
Risk assessment in neonatal early onset sepsisBacterial meningitis in infantsFrom the microbiome to the central nervous system, an update on the epidemiology and pathogenesis of bacterial meningitis in childhoodPrevention of neonatal group B streptococcus disease in the 21st centuryStratification of risk of early-onset sepsis in newborns ≥ 34 weeks' gestationLate-onset bloodstream infections in hospitalized term infants.Neonatal infectious diseases: evaluation of neonatal sepsis.Estimating the probability of neonatal early-onset infection on the basis of maternal risk factorsNeonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy.Bacterial isolates of early-onset neonatal sepsis and their antibiotic susceptibility pattern between 1998 and 2004: an audit from a center in India.Neonatal early-onset sepsis evaluations among well-appearing infants: projected impact of changes in CDC GBS guidelines.2010 perinatal GBS prevention guideline and resource utilization.Early-onset neonatal sepsis.Late-onset Leclercia adecarboxylata bacteraemia in a premature infant in the NICU.Clinical and Microbiologic Characteristics of Early-onset Sepsis Among Very Low Birth Weight Infants: Opportunities for Antibiotic Stewardship.Biomarkers for diagnosis of neonatal sepsis: a literature review.The association of maternal intrapartum subfebrile temperature and adverse obstetric and neonatal outcomes.Antenatal antibiotics: too much, too little, or just right?Early-onset neonatal sepsis: It is not only group B streptococcus.Early-onset neonatal sepsis: rate and organism pattern between 2003 and 2008.Aminoglycoside-Induced Cochleotoxicity: A Review.Results of a two-center, before and after study of piperacillin-tazobactam versus ampicillin and gentamicin as empiric therapy for suspected sepsis at birth in neonates ≤ 1500 g.
P2860
Q27026247-B649EE92-626F-4705-92C7-33F3830422C2Q28082173-45B06083-B0DC-43C5-9A32-1F69BEF658E0Q29248091-8F411976-AB86-4B1E-A03D-14211F171BE5Q29399413-6A7572E7-2F3D-4722-8626-5AC404C89A8BQ33837041-6681A92D-0A91-4BD3-8450-B34F5656643FQ34161144-D052293B-884C-4965-9BE9-390074C5DC10Q34332344-32D9FF21-AAF7-4389-ACEF-E4673C4D2B5EQ35530011-E8ECD13D-F330-4858-A4F9-ED2BAEAE33D6Q36089992-A016EFA7-C24B-4371-B310-0B93A997270DQ36239239-78EBC817-7B3C-4AFC-9326-B3E4F0FA07ADQ37195675-ECD0CB42-AEB9-4113-9C99-49E3E254AE30Q37522924-8D44B0B2-7A97-40A4-87B8-A80E0AFC8353Q37544901-2E2ABBC3-4B8E-4BCE-9B50-36F84C603A8AQ37906746-94A9B227-1728-4DEE-84A1-6DAE1FC59BF2Q38840297-A402F974-4173-4737-A3E2-5FB07A647C35Q39252687-BFD30510-4B9C-4604-9DFB-E3EB3D7CCD04Q40231823-66C0001A-F3DE-4965-86C2-2572E4910665Q42244586-C5EAB25E-3770-40D4-809A-BFFA8DEDED70Q42757343-2B3F4315-D376-4ABD-88BA-B638D6E50F60Q45361167-4806B6B5-8F9C-4819-BAC3-8593363BA3F3Q47134842-623A5A14-C6DE-41D2-A2A1-22E4B5F0EBFAQ54318853-165648D7-51F8-4922-AA96-E5A06C089E57
P2860
No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18 years.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
No change in the incidence of ...... ly-onset sepsis over 18 years.
@en
No change in the incidence of ...... ly-onset sepsis over 18 years.
@nl
type
label
No change in the incidence of ...... ly-onset sepsis over 18 years.
@en
No change in the incidence of ...... ly-onset sepsis over 18 years.
@nl
prefLabel
No change in the incidence of ...... ly-onset sepsis over 18 years.
@en
No change in the incidence of ...... ly-onset sepsis over 18 years.
@nl
P356
P1433
P1476
No change in the incidence of ...... ly-onset sepsis over 18 years.
@en
P2093
Eric C Eichenwald
Karen M Puopolo
P304
P356
10.1542/PEDS.2009-1573
P407
P577
2010-04-12T00:00:00Z